Blog

NMN vs. NR (Nicotinamide Riboside): What Human Trials Actually Show

10/09/2026

NMN and nicotinamide riboside (NR) are both precursors the body converts into NAD+, and the first randomized trial to give healthy adults each of them directly found they raised whole-blood NAD+ by a similar amount. In that 2025 Nature Metabolism study (65 healthy adults, 1,000 mg per day for 14 days), NR raised NAD+ by about 49 µM and NMN by about 43 µM, roughly a doubling for both. That is one short trial in healthy, mostly young adults, so it supports “comparable” and does not support “one is better.”

Table of Contents

  • The Head-to-Head Trial
  • What NR Has Shown on Its Own
  • What NMN Has Shown on Its Own
  • Doses, Forms, and the 2025 FDA Ruling
  • Taking Either One With Resveratrol
  • How to Choose Between Them

The Head-to-Head Trial

Researchers at Nestlé Research and collaborating institutions (Christen et al., Nature Metabolism, 2025) ran a randomized, open-label, placebo-controlled, four-arm trial in 65 healthy adults with a mean age of about 35. Participants took nicotinamide (500 mg daily), NR (1,000 mg daily), NMN (1,000 mg daily) or placebo for 14 days.

What they found:

  • NR and NMN raised whole-blood NAD+ about two-fold, comparably (NR +49.4 µM, NMN +43.1 µM, both p<0.001).
  • Nicotinamide did not raise NAD+ over the 14 days, though it acutely and transiently changed the NAD+ metabolome in the first hours.
  • All three were well tolerated. Of 65 participants, only three adverse events were judged probably related to the product: abdominal pain on placebo, hypotension on NR, and headache on NMN.
  • A gut component may be involved. The authors propose a gut-dependent model in which NR and NMN raise circulating NAD+ via the Preiss-Handler pathway. In lab experiments, human gut microbiota converted NR to nicotinamide and then nicotinic acid, and NMN and NR were rapidly broken down in isolated blood cells without raising NAD+ there.

Limits the authors state: the study population was healthy with above-normal NAD+ levels, some laboratory experiments did not capture effects seen in the body, and stool samples were not collected to confirm the microbial reactions. It was also open-label, 14 days long, and used 1,000 mg per day, which is higher than many label doses.

What NR Has Shown on Its Own

An earlier randomized, double-blind, placebo-controlled crossover trial (Martens et al., Nature Communications, 2018) gave 24 healthy adults aged 55-79 NR at 500 mg twice daily for six weeks. NR raised NAD+ in blood immune cells by about 60% compared with placebo and was well tolerated, with normal laboratory values throughout. Systolic and diastolic blood pressure trended down but not significantly overall; among participants with elevated baseline blood pressure, systolic pressure fell by about 9 mmHg on average. The study found no effects on exercise capacity, motor function or glucose control, and the authors note its small size and the lean, healthy population.

What NMN Has Shown on Its Own

NMN has been tested for safety and for physical-performance outcomes in older adults. A 12-week randomized trial in 108 adults aged 65 and older (Kim et al., Nutrients, 2022) gave 250 mg of NMN either in the morning or from 6 PM to bedtime. The evening group showed the largest effects on drowsiness and on a lower-limb function test (five-times sit-to-stand), though the sleep-quality score itself was not statistically significant. An earlier safety study (Irie et al., Endocrine Journal, 2020) gave 10 healthy men single doses of 100, 250 and 500 mg and found all doses well tolerated, with no severe adverse events.

What this does not show: these trials measured NAD+ levels and a limited set of functional outcomes. None shows that either precursor slows aging or treats a condition, and no trial we found compares long-term outcomes of NMN against NR.

Doses, Forms, and the 2025 FDA Ruling

The head-to-head trial used 1,000 mg of each precursor per day, and the 2018 NR trial used the same total daily dose; the 2018 authors noted this exceeds label-recommended amounts. Mega Resveratrol’s Mega NR provides 250 mg per capsule, and Super NMN is a 500 mg capsule. Trial doses are not recommendations; talk to a clinician before choosing a dose.

On regulation: on September 29, 2025 the FDA reversed its earlier position and confirmed that NMN is lawful in dietary supplements, after the Natural Products Association challenged the earlier exclusion. The FDA acknowledged NMN was marketed as a supplement in the U.S. as early as 2017.

Taking Either One With Resveratrol

Many people pair a NAD+ precursor with resveratrol. No trial we found tested which precursor pairs better with resveratrol, so any claim that one combination is superior is unproven. If you do stack them, start from pure resveratrol of verified purity and a precursor from a tested source. Our NMN vs. resveratrol page explains how the compounds differ, and our NMN vs. NMNH page covers the reduced form.

How to Choose Between Them

The human data don’t give a performance winner, so the practical differences decide it:

  • Evidence base: both raise blood NAD+ in human trials; NR has the 2018 six-week trial and NMN has the 2022 timing trial and the safety study.
  • Tolerance: both were well tolerated in these trials. If one upsets your stomach, that is a reason to switch.
  • Form and dose: capsules come in different strengths; compare cost per milligram of the active ingredient.
  • Verification: with either one, look for a certificate of analysis from an independent lab.

If you want to see what a supplement is doing for you, a blood NAD+ test is an option; see our guide on how to test your NAD+ levels. To compare products, browse Mega Resveratrol’s NAD+ precursors.

Frequently Asked Questions

Is NMN better than NR? 

Not according to the one direct human comparison. In a 2025 trial of 65 healthy adults, NR and NMN at 1,000 mg per day each roughly doubled whole-blood NAD+ over 14 days, and the increases were comparable.

Do NR and NMN raise NAD+ in humans? 

Yes, in the trials above. NR raised NAD+ in blood immune cells by about 60% in a six-week trial in adults aged 55-79, and in the 2025 trial both NR and NMN roughly doubled whole-blood NAD+ over 14 days.

Can you take NMN and NR together? 

We did not find a trial testing the combination, so its effects are unknown. Talk to a clinician before combining supplements.

Is NMN legal in the United States? 

Yes. The FDA confirmed on September 29, 2025 that NMN is lawful in dietary supplements, reversing its earlier position.

Which is safer, NMN or NR? 

In the head-to-head trial all precursors were well tolerated, with only three possibly related adverse events among 65 participants (one on placebo, one on NR, one on NMN). The trial was short and in healthy adults, so it can’t rank long-term safety.

Conclusion

NMN and NR have been compared directly in only one human trial, and it found them comparable at raising blood NAD+ over two weeks. Beyond that, the evidence for each is separate, small and short-term. Choose on tolerance, form, cost and verified purity rather than on claims that one is superior.

Disclaimer: This article is for informational purposes only and does not constitute medical advice. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare professional before starting any new supplement, especially if you are pregnant, nursing, taking medication, or have a medical condition.

Resources cited:

Select your currency
USD United States (US) dollar
×
Why Choose to Autoship?
  • Automatically re-order your favorite products on your schedule.
  • Easily change the products or shipping date for your upcoming Scheduled Orders. Go to:                                                               https://megaresveratrol.net/my-account/
  • Pause or cancel any time.

Autoship powered by QPilot Logo